
Sign up to save your podcasts
Or


This week please join author Yugo Yamashita and Associate Editor Joshua Beckman as they discuss the article "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20250303.648421
By Greg Hundley, MD and Peder Myhre, MD, PhD4.3
3030 ratings
This week please join author Yugo Yamashita and Associate Editor Joshua Beckman as they discuss the article "Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial)."
For the episode transcript, visit: https://www.ahajournals.org/do/10.1161/podcast.20250303.648421

134 Listeners

321 Listeners

504 Listeners

167 Listeners

906 Listeners

298 Listeners

3,374 Listeners

138 Listeners

1,150 Listeners

194 Listeners

94 Listeners

518 Listeners

367 Listeners

437 Listeners

375 Listeners